You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
明德生物(002932.SZ):擬出資4500萬元參投基金北京君聯昕遠壹號
格隆匯 06-27 20:54

格隆匯6月27日丨明德生物(002932.SZ)公佈,2022年6月27日,武漢明德生物科技股份有限公司與北京君遠企業管理諮詢合夥企業(有限合夥)(簡稱“北京君遠”)、北京君聯和泰創業投資合夥企業(有限合夥)(簡稱“君聯和泰”)、海南省康哲創業投資有限公司(簡稱“康哲創業”)共同簽署《北京君聯昕遠壹號創業投資合夥企業(有限合夥)有限合夥協議》,參與投資基金北京君聯昕遠壹號創業投資合夥企業(有限合夥)(以下簡稱“基金”)。

基金的規模為人民幣1.65億元,其中,北京君遠作為普通合夥人出資人民幣2000萬元,持股比例12.1212%;公司作為資金有限合夥人出資人民幣4500萬元,持股比例27.2727%;君聯和泰作為特殊有限合夥人(指普通合夥人認定為特殊有限合夥人的有限合夥人。特殊有限合夥人僅限於普通合夥人、管理人及其關聯方的管理團隊成員以及管理人認定的特定自然人,及/或團隊成員以及特定自然人直接或間接出資的實體或其他投資工具)以自有資金出資人民幣4000萬元,持股比例24.2424%;康哲創業作為資金有限合夥人出資人民幣6000萬元,持股比例36.3636%。基金主要投資領域為早期風險投資及成長期私募股權投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account